Specialty Drug Spending in 2018 Highlights SPT Week in Review

5. FDA Approves Two Fixed Dose HIV Treatments
New combination therapy gains approval for adult and pediatric patients with HIV-1. Read more.

4. Castration-Sensitive Prostate Cancer Drug Gets FDA Greenlight
FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer. Read more.

3. Top 3 Legislative Priorities for Pharmacists
Direct and indirect remuneration fees remain a top concern for pharmacists in 2018. Read more.

2. Personalized Medicine Approvals Continued to Surge in 2017
Thirty-five percent of drug approvals in 2017 were personalized drugs. Read more.

1. Top 8 Specialty Drug Categories Driving Spending in 2018
Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending. Read more.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

Top news of the week from Specialty Pharmacy Times.
Medicare Part D patients can face thousands of dollars in out-of-pocket costs for a single specialty tier drug.
Blockchain, mobile health, and predictive analytics are just a few areas that could improve patient care and enhance the pharmacy industry.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.